EUVIMEDEUVIMED entdecken
Crossref

Design, synthesis, and characterization of species-independent h/mGPR35 agonists for MAFLD/MASH

Hui Wen, Junxiang Cheng, Zhiwei Wang, Tao Hou, Yuting Li, Zhongjing Qiao, Han Zhou, Yanfang Liu, Yaopeng Zhao, Xinmiao Liang

Bioorganic Chemistry · 2026-09 · 180 · 110208

DOI: 10.1016/j.bioorg.2026.110208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-09. Verfasst von Hui Wen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center, Na…. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Drug Design, Fatty Liver, Coumarins. Die Arbeit nennt 40 Literaturangaben. Gefördert von: Central Asian Center of Drug Discovery and Development of Chinese Academy of Sciences, DICP.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

G protein-coupled receptor 35 (GPR35) has emerged as a potential therapeutic target for metabolic dysfunction-associated fatty liver disease (MAFLD) and metabolic dysfunction-associated steatohepatitis (MASH). However, the sequence identity between human and mouse GPR35 is only 72%, which severely limits the development of species-independent active ligands for GPR35 and consequently hinders pharmacological studies targeting GPR35 in MAFLD/MASH. In this work, a series of novel GPR35 agonists based on the coumarin scaffold were developed, exhibiting low species differences between hGPR35 and mGPR35. Some of these agonists demonstrated low nanomolar potency, such as compound 6l (hEC50 = 30 nM, mEC50 = 21 nM) and compound 9f (hEC50 = 12 nM, mEC50 = 2 nM). The key binding sites of 6l and 9f with the h/mGPR35 receptor were further identified, respectively. Both compounds exhibited excellent lipid-lowering effects in in vitro and in vivo models. In a high-fat diet-induced mouse model of MASH, 6l and 9f significantly alleviated key pathological drivers of disease progression, including hepatic steatosis, lipid metabolism disorders, liver inflammation and fibrosis. Collectively, this study provides a class of novel agonists with high potency and low species differences for h/mGPR35, laying a foundation for further exploration of the pharmacological relationship between GPR35 and MAFLD/MASH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledDrug DesignFatty LiverCoumarinsNon-alcoholic Fatty Liver DiseaseAnimalsHumansMiceStructure-Activity RelationshipMolecular StructureDose-Response Relationship, DrugMaleMice, Inbred C57BL

Stichwörter der Autor:innen

GPR35 agonistLipid-loweringMAFLD/MASHSpecies-independent

Substanzen

Receptors, G-Protein-CoupledGPR35 protein, humanCoumarins

Autor:innen und Institutionen

  • Jiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Traditional Chinese Medicine, Ganjiang Chinese Medicine Innovation Center, Nanchang 330000, China.
  • State Key Lab of Phytochemistry and Natural Medicines, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China; Jiangxi Provincial Key Laboratory for Pharmacodynamic Material Basis of Tra…

Förderung

  • Central Asian Center of Drug Discovery and Development of Chinese Academy of Sciences
  • DICP

Zitieren

APA

Wen, H., Cheng, J., Wang, Z., Hou, T., Li, Y., Qiao, Z., Zhou, H., Liu, Y., Zhao, Y., & Liang, X. (2026). Design, synthesis, and characterization of species-independent h/mGPR35 agonists for MAFLD/MASH. Bioorganic Chemistry, 180, 110208. https://doi.org/10.1016/j.bioorg.2026.110208

Vancouver

Wen H, Cheng J, Wang Z, Hou T, Li Y, Qiao Z, et al. Design, synthesis, and characterization of species-independent h/mGPR35 agonists for MAFLD/MASH. Bioorganic Chemistry. 2026;180:110208. doi:10.1016/j.bioorg.2026.110208

BibTeX
@article{Wen2026,
  author = {Wen, Hui and Cheng, Junxiang and Wang, Zhiwei and Hou, Tao and Li, Yuting and Qiao, Zhongjing and Zhou, Han and Liu, Yanfang and Zhao, Yaopeng and Liang, Xinmiao},
  title = {Design, synthesis, and characterization of species-independent h/mGPR35 agonists for MAFLD/MASH},
  journal = {Bioorganic Chemistry},
  year = {2026},
  volume = {180},
  pages = {110208},
  doi = {10.1016/j.bioorg.2026.110208}
}
Kostenlos starten →